- Home
- SRFM vs SGHT Comparison
SRFM vs SGHT Comparison
Compare SRFM & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- SGHT
- Stock Information
- Founded
- SRFM 2011
- SGHT 2011
- Country
- SRFM United States
- SGHT United States
- Employees
- SRFM N/A
- SGHT N/A
- Industry
- SRFM Transportation Services
- SGHT Medical Specialities
- Sector
- SRFM Consumer Discretionary
- SGHT Health Care
- Exchange
- SRFM Nasdaq
- SGHT Nasdaq
- Market Cap
- SRFM 185.9M
- SGHT 193.2M
- IPO Year
- SRFM 2023
- SGHT 2021
- Fundamental
- Price
- SRFM $4.53
- SGHT $3.69
- Analyst Decision
- SRFM Buy
- SGHT Buy
- Analyst Count
- SRFM 4
- SGHT 8
- Target Price
- SRFM $5.75
- SGHT $4.29
- AVG Volume (30 Days)
- SRFM 1.7M
- SGHT 108.1K
- Earning Date
- SRFM 11-13-2025
- SGHT 11-06-2025
- Dividend Yield
- SRFM N/A
- SGHT N/A
- EPS Growth
- SRFM N/A
- SGHT N/A
- EPS
- SRFM N/A
- SGHT N/A
- Revenue
- SRFM $107,372,000.00
- SGHT $76,303,000.00
- Revenue This Year
- SRFM N/A
- SGHT N/A
- Revenue Next Year
- SRFM $18.06
- SGHT $12.04
- P/E Ratio
- SRFM N/A
- SGHT N/A
- Revenue Growth
- SRFM N/A
- SGHT N/A
- 52 Week Low
- SRFM $1.10
- SGHT $2.03
- 52 Week High
- SRFM $9.91
- SGHT $7.00
- Technical
- Relative Strength Index (RSI)
- SRFM 54.30
- SGHT 48.20
- Support Level
- SRFM $4.13
- SGHT $3.39
- Resistance Level
- SRFM $4.57
- SGHT $3.65
- Average True Range (ATR)
- SRFM 0.27
- SGHT 0.18
- MACD
- SRFM 0.04
- SGHT -0.03
- Stochastic Oscillator
- SRFM 84.88
- SGHT 44.68
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.